ReviewInternational journal of general medicine2026
Diabetic Neuropathy: From Etiopathogenesis to Integrative Therapeutic Strategies with Traditional Chinese Medicine.
Review in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic neuropathy is a common and disabling complication of diabetes leading to numbness, pain, sensory loss and reduced quality of life. This review summarizes its diagnosis, epidemiology, genetic basis, pathophysiological mechanisms and current treatment strategies, with a focus on the role of traditional Chinese medicine (TCM). Its current common diagnostic methods include nerve conduction studies and corneal confocal microscopy. The development of diabetic neuropathy has been closely linked to chronic hyperglycemia, metabolic disorders, oxidative stress, inflammation, and mitochondrial dysfunction, and the current treatment mainly relies on glycemic control, neuroprotective agents, pain relief, exercise, and physical therapy, despite clinical benefits remain limited in many patients. TCM has shown potential value through herbal formulas, active natural compounds, acupuncture, moxibustion, and external therapies such as herbal foot baths, which have shown efficacies in relieving symptoms and protecting nerve function through antioxidant, anti-inflammatory, and autophagy-related effects, as well as regulation of gut microbiota. This review also highlights current research gaps, including uneven study quality, insufficient mechanistic evidence, and lack of standardized evaluation. Overall, we integrate recent basic and clinical evidence to provide a clearer framework for future research and more standardized development of TCM-based strategies for diabetic neuropathy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.